DaVita (STU:TRL) Institutional Ownership : 28.01% (As of Dec. 13, 2024)

View and export this data going back to 1995. Start your Free Trial

What is DaVita Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DaVita's institutional ownership is 28.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DaVita's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DaVita's Float Percentage Of Total Shares Outstanding is 54.43%.

DaVita Institutional Ownership Historical Data

The historical data trend for DaVita's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Institutional Ownership Chart

DaVita Historical Data

The historical data trend for DaVita can be seen below:

	2024-02-29	2024-03-31	2024-04-30	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30
Institutional Ownership	28.08	29.14	29.22	29.34	30.47	28.90	29.75	27.88	28.08	28.01

DaVita Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (STU:TRL) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

DVA:USA 0I7E:UK TRL:Germany DVAI34:Brazil

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

DaVita Headlines

No Headlines